| EC Number | Application | Comment | Organism |
|---|---|---|---|
| 3.5.1.88 | medicine | peptide deformylase is a therapeutic target for tuberculosis | Homo sapiens |
| 3.5.1.88 | medicine | peptide deformylase is a therapeutic target for antibacterial drug discovery | Escherichia coli |
| 3.5.1.88 | medicine | peptide deformylase is a therapeutic target for antibacterial drug discovery | Streptococcus pneumoniae |
| 3.5.1.88 | medicine | peptide deformylase is a therapeutic target for antibacterial drug discovery | Staphylococcus aureus |
| 3.5.1.88 | medicine | peptide deformylase is a therapeutic target for antibacterial drug discovery | Staphylococcus epidermidis |
| 3.5.1.88 | medicine | peptide deformylase is a therapeutic target for antibacterial drug discovery | Enterococcus sp. |
| 3.5.1.88 | medicine | peptide deformylase is a therapeutic target for antibacterial drug discovery | Bacillus subtilis |
| 3.5.1.88 | medicine | peptide deformylase is a therapeutic target for antibacterial drug discovery | Moraxella catarrhalis |
| 3.5.1.88 | medicine | peptide deformylase is a therapeutic target for antibacterial drug discovery | Neisseria gonorrhoeae |
| 3.5.1.88 | medicine | peptide deformylase is a therapeutic target for antibacterial drug discovery | Stenotrophomonas maltophilia |
| 3.5.1.88 | medicine | peptide deformylase is a therapeutic target for antibacterial drug discovery | Bacteroides fragilis |
| 3.5.1.88 | medicine | peptide deformylase is a therapeutic target for antibacterial drug discovery | Klebsiella pneumoniae |
| 3.5.1.88 | medicine | peptide deformylase is a therapeutic target for antibacterial drug discovery | Enterobacter cloacae |
| 3.5.1.88 | medicine | peptide deformylase is a therapeutic target for antibacterial drug discovery | Pseudomonas aeruginosa |
| 3.5.1.88 | medicine | peptide deformylase is a therapeutic target for antibacterial drug discovery | Mycobacterium tuberculosis variant bovis |
| 3.5.1.88 | medicine | peptide deformylase is a therapeutic target for tuberculosis | Mycobacterium tuberculosis |
| EC Number | Inhibitors | Comment | Organism | Structure |
|---|---|---|---|---|
| 3.5.1.88 | (2R)-N-[(3S)-2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-4,4-dimethylpent-1-en-3-yl]-2-[[formyl(hydroxy)amino]methyl]hexanamide | - |
Homo sapiens | |
| 3.5.1.88 | (2R)-N-[(3S)-2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-4,4-dimethylpent-1-en-3-yl]-2-[[formyl(hydroxy)amino]methyl]hexanamide | - |
Mycobacterium tuberculosis | |
| 3.5.1.88 | actinonin | - |
Bacillus subtilis | |
| 3.5.1.88 | actinonin | - |
Bacteroides fragilis | |
| 3.5.1.88 | actinonin | - |
Enterobacter cloacae | |
| 3.5.1.88 | actinonin | - |
Enterococcus sp. | |
| 3.5.1.88 | actinonin | - |
Escherichia coli | |
| 3.5.1.88 | actinonin | - |
Homo sapiens | |
| 3.5.1.88 | actinonin | - |
Klebsiella pneumoniae | |
| 3.5.1.88 | actinonin | - |
Moraxella catarrhalis | |
| 3.5.1.88 | actinonin | - |
Mycobacterium tuberculosis | |
| 3.5.1.88 | actinonin | - |
Mycobacterium tuberculosis variant bovis | |
| 3.5.1.88 | actinonin | - |
Neisseria gonorrhoeae | |
| 3.5.1.88 | actinonin | - |
Plasmodium falciparum | |
| 3.5.1.88 | actinonin | - |
Pseudomonas aeruginosa | |
| 3.5.1.88 | actinonin | - |
Staphylococcus aureus | |
| 3.5.1.88 | actinonin | - |
Staphylococcus epidermidis | |
| 3.5.1.88 | actinonin | - |
Stenotrophomonas maltophilia | |
| 3.5.1.88 | actinonin | - |
Streptococcus pneumoniae | |
| 3.5.1.88 | BB-3497 | - |
Bacillus subtilis | |
| 3.5.1.88 | BB-3497 | - |
Bacteroides fragilis | |
| 3.5.1.88 | BB-3497 | - |
Enterobacter cloacae | |
| 3.5.1.88 | BB-3497 | - |
Enterococcus sp. | |
| 3.5.1.88 | BB-3497 | - |
Escherichia coli | |
| 3.5.1.88 | BB-3497 | - |
Homo sapiens | |
| 3.5.1.88 | BB-3497 | - |
Klebsiella pneumoniae | |
| 3.5.1.88 | BB-3497 | - |
Moraxella catarrhalis | |
| 3.5.1.88 | BB-3497 | - |
Mycobacterium tuberculosis | |
| 3.5.1.88 | BB-3497 | - |
Mycobacterium tuberculosis variant bovis | |
| 3.5.1.88 | BB-3497 | - |
Neisseria gonorrhoeae | |
| 3.5.1.88 | BB-3497 | - |
Plasmodium falciparum | |
| 3.5.1.88 | BB-3497 | - |
Pseudomonas aeruginosa | |
| 3.5.1.88 | BB-3497 | - |
Staphylococcus aureus | |
| 3.5.1.88 | BB-3497 | - |
Staphylococcus epidermidis | |
| 3.5.1.88 | BB-3497 | - |
Stenotrophomonas maltophilia | |
| 3.5.1.88 | BB-3497 | - |
Streptococcus pneumoniae | |
| 3.5.1.88 | BB-81384 | - |
Bacillus subtilis | |
| 3.5.1.88 | BB-81384 | - |
Bacteroides fragilis | |
| 3.5.1.88 | BB-81384 | - |
Enterobacter cloacae | |
| 3.5.1.88 | BB-81384 | - |
Enterococcus sp. | |
| 3.5.1.88 | BB-81384 | - |
Escherichia coli | |
| 3.5.1.88 | BB-81384 | - |
Homo sapiens | |
| 3.5.1.88 | BB-81384 | - |
Klebsiella pneumoniae | |
| 3.5.1.88 | BB-81384 | - |
Moraxella catarrhalis | |
| 3.5.1.88 | BB-81384 | - |
Mycobacterium tuberculosis | |
| 3.5.1.88 | BB-81384 | - |
Mycobacterium tuberculosis variant bovis | |
| 3.5.1.88 | BB-81384 | - |
Neisseria gonorrhoeae | |
| 3.5.1.88 | BB-81384 | - |
Plasmodium falciparum | |
| 3.5.1.88 | BB-81384 | - |
Pseudomonas aeruginosa | |
| 3.5.1.88 | BB-81384 | - |
Staphylococcus aureus | |
| 3.5.1.88 | BB-81384 | - |
Staphylococcus epidermidis | |
| 3.5.1.88 | BB-81384 | - |
Stenotrophomonas maltophilia | |
| 3.5.1.88 | BB-81384 | - |
Streptococcus pneumoniae | |
| 3.5.1.88 | BB-83698 | - |
Bacillus subtilis | |
| 3.5.1.88 | BB-83698 | - |
Bacteroides fragilis | |
| 3.5.1.88 | BB-83698 | - |
Enterobacter cloacae | |
| 3.5.1.88 | BB-83698 | - |
Enterococcus sp. | |
| 3.5.1.88 | BB-83698 | - |
Escherichia coli | |
| 3.5.1.88 | BB-83698 | - |
Homo sapiens | |
| 3.5.1.88 | BB-83698 | - |
Klebsiella pneumoniae | |
| 3.5.1.88 | BB-83698 | - |
Moraxella catarrhalis | |
| 3.5.1.88 | BB-83698 | - |
Mycobacterium tuberculosis | |
| 3.5.1.88 | BB-83698 | - |
Mycobacterium tuberculosis variant bovis | |
| 3.5.1.88 | BB-83698 | - |
Neisseria gonorrhoeae | |
| 3.5.1.88 | BB-83698 | - |
Plasmodium falciparum | |
| 3.5.1.88 | BB-83698 | - |
Pseudomonas aeruginosa | |
| 3.5.1.88 | BB-83698 | - |
Staphylococcus aureus | |
| 3.5.1.88 | BB-83698 | - |
Staphylococcus epidermidis | |
| 3.5.1.88 | BB-83698 | - |
Stenotrophomonas maltophilia | |
| 3.5.1.88 | BB-83698 | - |
Streptococcus pneumoniae | |
| 3.5.1.88 | tert-butyl 1-[(2R)-2-[2-(hydroxyamino)-2-oxoethyl]hexanoyl]-L-prolinate | - |
Homo sapiens | |
| 3.5.1.88 | tert-butyl 1-[(2R)-2-[2-(hydroxyamino)-2-oxoethyl]hexanoyl]-L-prolinate | - |
Mycobacterium tuberculosis | |
| 3.5.1.88 | VIC-104959 | LBM415 | Bacillus subtilis | |
| 3.5.1.88 | VIC-104959 | LBM415 | Bacteroides fragilis | |
| 3.5.1.88 | VIC-104959 | LBM415 | Enterobacter cloacae | |
| 3.5.1.88 | VIC-104959 | LBM415 | Enterococcus sp. | |
| 3.5.1.88 | VIC-104959 | LBM415 | Escherichia coli | |
| 3.5.1.88 | VIC-104959 | LBM415 | Homo sapiens | |
| 3.5.1.88 | VIC-104959 | LBM415 | Klebsiella pneumoniae | |
| 3.5.1.88 | VIC-104959 | LBM415 | Moraxella catarrhalis | |
| 3.5.1.88 | VIC-104959 | LBM415 | Mycobacterium tuberculosis | |
| 3.5.1.88 | VIC-104959 | LBM415 | Mycobacterium tuberculosis variant bovis | |
| 3.5.1.88 | VIC-104959 | LBM415 | Neisseria gonorrhoeae | |
| 3.5.1.88 | VIC-104959 | LBM415 | Plasmodium falciparum | |
| 3.5.1.88 | VIC-104959 | LBM415 | Pseudomonas aeruginosa | |
| 3.5.1.88 | VIC-104959 | LBM415 | Staphylococcus aureus | |
| 3.5.1.88 | VIC-104959 | LBM415 | Staphylococcus epidermidis | |
| 3.5.1.88 | VIC-104959 | LBM415 | Stenotrophomonas maltophilia | |
| 3.5.1.88 | VIC-104959 | LBM415 | Streptococcus pneumoniae | |
| 3.5.1.88 | VRC-3375 | - |
Bacillus subtilis | |
| 3.5.1.88 | VRC-3375 | - |
Bacteroides fragilis | |
| 3.5.1.88 | VRC-3375 | - |
Enterobacter cloacae | |
| 3.5.1.88 | VRC-3375 | - |
Enterococcus sp. | |
| 3.5.1.88 | VRC-3375 | - |
Escherichia coli | |
| 3.5.1.88 | VRC-3375 | - |
Homo sapiens | |
| 3.5.1.88 | VRC-3375 | - |
Klebsiella pneumoniae | |
| 3.5.1.88 | VRC-3375 | - |
Moraxella catarrhalis | |
| 3.5.1.88 | VRC-3375 | - |
Mycobacterium tuberculosis | |
| 3.5.1.88 | VRC-3375 | - |
Mycobacterium tuberculosis variant bovis | |
| 3.5.1.88 | VRC-3375 | - |
Neisseria gonorrhoeae | |
| 3.5.1.88 | VRC-3375 | - |
Plasmodium falciparum | |
| 3.5.1.88 | VRC-3375 | - |
Pseudomonas aeruginosa | |
| 3.5.1.88 | VRC-3375 | - |
Staphylococcus aureus | |
| 3.5.1.88 | VRC-3375 | - |
Staphylococcus epidermidis | |
| 3.5.1.88 | VRC-3375 | - |
Stenotrophomonas maltophilia | |
| 3.5.1.88 | VRC-3375 | - |
Streptococcus pneumoniae | |
| 3.5.1.88 | VRC-4307 | - |
Bacillus subtilis | |
| 3.5.1.88 | VRC-4307 | - |
Bacteroides fragilis | |
| 3.5.1.88 | VRC-4307 | - |
Enterobacter cloacae | |
| 3.5.1.88 | VRC-4307 | - |
Enterococcus sp. | |
| 3.5.1.88 | VRC-4307 | - |
Escherichia coli | |
| 3.5.1.88 | VRC-4307 | - |
Homo sapiens | |
| 3.5.1.88 | VRC-4307 | - |
Klebsiella pneumoniae | |
| 3.5.1.88 | VRC-4307 | - |
Moraxella catarrhalis | |
| 3.5.1.88 | VRC-4307 | - |
Mycobacterium tuberculosis | |
| 3.5.1.88 | VRC-4307 | - |
Mycobacterium tuberculosis variant bovis | |
| 3.5.1.88 | VRC-4307 | - |
Neisseria gonorrhoeae | |
| 3.5.1.88 | VRC-4307 | - |
Plasmodium falciparum | |
| 3.5.1.88 | VRC-4307 | - |
Pseudomonas aeruginosa | |
| 3.5.1.88 | VRC-4307 | - |
Staphylococcus aureus | |
| 3.5.1.88 | VRC-4307 | - |
Staphylococcus epidermidis | |
| 3.5.1.88 | VRC-4307 | - |
Stenotrophomonas maltophilia | |
| 3.5.1.88 | VRC-4307 | - |
Streptococcus pneumoniae |
| EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
|---|---|---|---|---|---|---|---|
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | Homo sapiens | - |
formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | Escherichia coli | - |
formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | Plasmodium falciparum | - |
formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | Streptococcus pneumoniae | - |
formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | Staphylococcus aureus | - |
formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | Staphylococcus epidermidis | - |
formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | Enterococcus sp. | - |
formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | Bacillus subtilis | - |
formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | Moraxella catarrhalis | - |
formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | Neisseria gonorrhoeae | - |
formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | Stenotrophomonas maltophilia | - |
formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | Bacteroides fragilis | - |
formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | Klebsiella pneumoniae | - |
formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | Enterobacter cloacae | - |
formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | Pseudomonas aeruginosa | - |
formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | Mycobacterium tuberculosis variant bovis | - |
formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | Mycobacterium tuberculosis | - |
formate + L-methionine-polypeptide | - |
? |
| EC Number | Organism | UniProt | Comment | Textmining |
|---|---|---|---|---|
| 3.5.1.88 | Bacillus subtilis | - |
- |
- |
| 3.5.1.88 | Bacteroides fragilis | - |
- |
- |
| 3.5.1.88 | Enterobacter cloacae | - |
- |
- |
| 3.5.1.88 | Enterococcus sp. | - |
- |
- |
| 3.5.1.88 | Escherichia coli | - |
- |
- |
| 3.5.1.88 | Homo sapiens | - |
- |
- |
| 3.5.1.88 | Klebsiella pneumoniae | - |
- |
- |
| 3.5.1.88 | Moraxella catarrhalis | - |
- |
- |
| 3.5.1.88 | Mycobacterium tuberculosis | - |
- |
- |
| 3.5.1.88 | Mycobacterium tuberculosis variant bovis | - |
- |
- |
| 3.5.1.88 | Neisseria gonorrhoeae | - |
- |
- |
| 3.5.1.88 | Plasmodium falciparum | - |
- |
- |
| 3.5.1.88 | Pseudomonas aeruginosa | - |
- |
- |
| 3.5.1.88 | Staphylococcus aureus | - |
- |
- |
| 3.5.1.88 | Staphylococcus epidermidis | - |
- |
- |
| 3.5.1.88 | Stenotrophomonas maltophilia | - |
- |
- |
| 3.5.1.88 | Streptococcus pneumoniae | - |
- |
- |
| EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|---|
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | - |
Homo sapiens | formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | - |
Escherichia coli | formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | - |
Plasmodium falciparum | formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | - |
Streptococcus pneumoniae | formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | - |
Staphylococcus aureus | formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | - |
Staphylococcus epidermidis | formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | - |
Enterococcus sp. | formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | - |
Bacillus subtilis | formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | - |
Moraxella catarrhalis | formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | - |
Neisseria gonorrhoeae | formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | - |
Stenotrophomonas maltophilia | formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | - |
Bacteroides fragilis | formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | - |
Klebsiella pneumoniae | formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | - |
Enterobacter cloacae | formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | - |
Pseudomonas aeruginosa | formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | - |
Mycobacterium tuberculosis variant bovis | formate + L-methionine-polypeptide | - |
? | |
| 3.5.1.88 | N-formyl-L-methionine-polypeptide + H2O | - |
Mycobacterium tuberculosis | formate + L-methionine-polypeptide | - |
? |
| EC Number | Synonyms | Comment | Organism |
|---|---|---|---|
| 3.5.1.88 | - |
Homo sapiens | |
| 3.5.1.88 | - |
Escherichia coli | |
| 3.5.1.88 | - |
Plasmodium falciparum | |
| 3.5.1.88 | - |
Streptococcus pneumoniae | |
| 3.5.1.88 | - |
Staphylococcus aureus | |
| 3.5.1.88 | - |
Staphylococcus epidermidis | |
| 3.5.1.88 | - |
Enterococcus sp. | |
| 3.5.1.88 | - |
Bacillus subtilis | |
| 3.5.1.88 | - |
Moraxella catarrhalis | |
| 3.5.1.88 | - |
Neisseria gonorrhoeae | |
| 3.5.1.88 | - |
Stenotrophomonas maltophilia | |
| 3.5.1.88 | - |
Bacteroides fragilis | |
| 3.5.1.88 | - |
Klebsiella pneumoniae | |
| 3.5.1.88 | - |
Enterobacter cloacae | |
| 3.5.1.88 | - |
Pseudomonas aeruginosa | |
| 3.5.1.88 | - |
Mycobacterium tuberculosis variant bovis | |
| 3.5.1.88 | - |
Mycobacterium tuberculosis |
| EC Number | General Information | Comment | Organism |
|---|---|---|---|
| 3.5.1.88 | physiological function | PDF plays a critical role in mediating the maturation process of the nascent polypeptides partly due to the necessity of removing the N-formyl group to render nascent polypeptides available for cleavage of the N-terminal methionine residue by methionine amino peptidase | Homo sapiens |
| 3.5.1.88 | physiological function | PDF plays a critical role in mediating the maturation process of the nascent polypeptides partly due to the necessity of removing the N-formyl group to render nascent polypeptides available for cleavage of the N-terminal methionine residue by methionine amino peptidase | Escherichia coli |
| 3.5.1.88 | physiological function | PDF plays a critical role in mediating the maturation process of the nascent polypeptides partly due to the necessity of removing the N-formyl group to render nascent polypeptides available for cleavage of the N-terminal methionine residue by methionine amino peptidase | Plasmodium falciparum |
| 3.5.1.88 | physiological function | PDF plays a critical role in mediating the maturation process of the nascent polypeptides partly due to the necessity of removing the N-formyl group to render nascent polypeptides available for cleavage of the N-terminal methionine residue by methionine amino peptidase | Streptococcus pneumoniae |
| 3.5.1.88 | physiological function | PDF plays a critical role in mediating the maturation process of the nascent polypeptides partly due to the necessity of removing the N-formyl group to render nascent polypeptides available for cleavage of the N-terminal methionine residue by methionine amino peptidase | Staphylococcus aureus |
| 3.5.1.88 | physiological function | PDF plays a critical role in mediating the maturation process of the nascent polypeptides partly due to the necessity of removing the N-formyl group to render nascent polypeptides available for cleavage of the N-terminal methionine residue by methionine amino peptidase | Staphylococcus epidermidis |
| 3.5.1.88 | physiological function | PDF plays a critical role in mediating the maturation process of the nascent polypeptides partly due to the necessity of removing the N-formyl group to render nascent polypeptides available for cleavage of the N-terminal methionine residue by methionine amino peptidase | Enterococcus sp. |
| 3.5.1.88 | physiological function | PDF plays a critical role in mediating the maturation process of the nascent polypeptides partly due to the necessity of removing the N-formyl group to render nascent polypeptides available for cleavage of the N-terminal methionine residue by methionine amino peptidase | Bacillus subtilis |
| 3.5.1.88 | physiological function | PDF plays a critical role in mediating the maturation process of the nascent polypeptides partly due to the necessity of removing the N-formyl group to render nascent polypeptides available for cleavage of the N-terminal methionine residue by methionine amino peptidase | Moraxella catarrhalis |
| 3.5.1.88 | physiological function | PDF plays a critical role in mediating the maturation process of the nascent polypeptides partly due to the necessity of removing the N-formyl group to render nascent polypeptides available for cleavage of the N-terminal methionine residue by methionine amino peptidase | Neisseria gonorrhoeae |
| 3.5.1.88 | physiological function | PDF plays a critical role in mediating the maturation process of the nascent polypeptides partly due to the necessity of removing the N-formyl group to render nascent polypeptides available for cleavage of the N-terminal methionine residue by methionine amino peptidase | Stenotrophomonas maltophilia |
| 3.5.1.88 | physiological function | PDF plays a critical role in mediating the maturation process of the nascent polypeptides partly due to the necessity of removing the N-formyl group to render nascent polypeptides available for cleavage of the N-terminal methionine residue by methionine amino peptidase | Bacteroides fragilis |
| 3.5.1.88 | physiological function | PDF plays a critical role in mediating the maturation process of the nascent polypeptides partly due to the necessity of removing the N-formyl group to render nascent polypeptides available for cleavage of the N-terminal methionine residue by methionine amino peptidase | Klebsiella pneumoniae |
| 3.5.1.88 | physiological function | PDF plays a critical role in mediating the maturation process of the nascent polypeptides partly due to the necessity of removing the N-formyl group to render nascent polypeptides available for cleavage of the N-terminal methionine residue by methionine amino peptidase | Enterobacter cloacae |
| 3.5.1.88 | physiological function | PDF plays a critical role in mediating the maturation process of the nascent polypeptides partly due to the necessity of removing the N-formyl group to render nascent polypeptides available for cleavage of the N-terminal methionine residue by methionine amino peptidase | Pseudomonas aeruginosa |
| 3.5.1.88 | physiological function | PDF plays a critical role in mediating the maturation process of the nascent polypeptides partly due to the necessity of removing the N-formyl group to render nascent polypeptides available for cleavage of the N-terminal methionine residue by methionine amino peptidase | Mycobacterium tuberculosis variant bovis |
| 3.5.1.88 | physiological function | PDF plays a critical role in mediating the maturation process of the nascent polypeptides partly due to the necessity of removing the N-formyl group to render nascent polypeptides available for cleavage of the N-terminal methionine residue by methionine amino peptidase | Mycobacterium tuberculosis |